Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 258

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 258
---
options and rights(a) |     |     | Weighted-averageexercise price of stockoptions and rights$ |          |     | Number of shares ofcommon stockremaining available forfuture issuance underequity compensationplans (excludingsecurities reflected incolumn (a)) |     |
|:----------------------------------------------------------------------------------------------------------------------|:----|:---------------------------------------------------------------------------------------------------|----:|:----|:-----------------------------------------------------------|---------:|:----|:-------------------------------------------------------------------------------------------------------------------------------------------------|----:|
| Equity compensation plans approved by security holders - 2017 Plan(1)                                                 |     |                                                                                                    | 288 |     | $                                                          |    21.40 |     |                                                                                                                                                  | 144 |
| Equity compensation plans not approved by security holders - Del Mar (BC) 2013 Amended and Restated Stock Option Plan |     |                                                                                                    |   — |     | $                                                          | 2,060.08 |     |                                                                                                                                                  |   — |
| Totals                                                                                                                |     |                                                                                                    | 288 |     | $                                                          |    30.70 |     |                                                                                                                                                  | 144 |

| (1) | The Del Mar (BC) 2013 Amended and Restated Stock Option Plan refers to the Company’s previous equity compensation plan. |

| (2) | The balance of144shares of common stock available for issuance under the 2017 Plan as of June 30, 2024, is net of stock options previously exercised. |

The maximum number of shares of Company common stock with respect to which any one participant may be granted awards during any calendar year is 8 % of the Company’s fully diluted shares of common stock on the date of grant (excluding the number of shares of common stock issued under the 2017 Plan and/or the Legacy Plan or subject to outstanding awards granted under the 2017 Plan and/or the Legacy Plan). No award will be granted under the 2017 Plan on, or after, July 7, 2027.

Stock options

During the year ended June 30, 2024, a total of 89 stock options to purchase shares of common stock were granted to directors and officers of the Company. The 89 options granted have an exercise price of $ 4.655 per share and vest as to 25% on August 30, 2024, with the remaining portion vesting in equal monthly installments over a period of 36 months from September 30, 2024 to September 30, 2027.